Concepedia

Publication | Open Access

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

DOIFull Paper Access

145

Citations

26

References

2018

Year

Heikki Joensuu, Judith Fraser, Hans Wildiers, Riikka Huovinen, Päivi Auvinen, Meri Utriainen, Paul Nyandoto, Kenneth Villman, Päivi Halonen, Helena Granstam-Björneklett,
JAMA Oncology

Abstract

ClinicalTrials.gov Identifier: NCT00593697.

References

YearCitations

Page 1